Marathon Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Hold |
1,127
| – | – | 0.12% | 97 |
|
|
2025
Q1 | $561K | Sell |
1,127
-50
| -4% | -$24.9K | 0.15% | 85 |
|
|
2024
Q4 | $612K | Buy |
1,177
+2
| +0.2% | +$1.04K | 0.15% | 84 |
|
|
2024
Q3 | $727K | Hold |
1,175
| – | – | 0.18% | 79 |
|
|
2024
Q2 | $650K | Hold |
1,175
| – | – | 0.17% | 78 |
|
|
2024
Q1 | $683K | Sell |
1,175
-25
| -2% | -$14.5K | 0.16% | 80 |
|
|
2023
Q4 | $637K | Hold |
1,200
| – | – | 0.16% | 87 |
|
|
2023
Q3 | $607K | Hold |
1,200
| – | – | 0.15% | 85 |
|
|
2023
Q2 | $626K | Hold |
1,200
| – | – | 0.15% | 85 |
|
|
2023
Q1 | $692K | Hold |
1,200
| – | – | 0.17% | 84 |
|
|
2022
Q4 | $661K | Hold |
1,200
| – | – | 0.18% | 77 |
|
|
2022
Q3 | $609K | Hold |
1,200
| – | – | 0.17% | 84 |
|
|
2022
Q2 | $652K | Buy |
+1,200
| New | +$652K | 0.21% | 75 |
|
|
2022
Q1 | – | Sell |
-1,225
| Closed | -$817K | – | 162 |
|
|
2021
Q4 | $817K | Sell |
1,225
-25
| -2% | -$16.7K | 0.19% | 76 |
|
|
2021
Q3 | $715K | Hold |
1,250
| – | – | 0.16% | 88 |
|
|
2021
Q2 | $630K | Hold |
1,250
| – | – | 0.15% | 83 |
|
|
2021
Q1 | $570K | Hold |
1,250
| – | – | 0.15% | 81 |
|
|
2020
Q4 | $582K | Sell |
1,250
-50
| -4% | -$23.3K | 0.17% | 73 |
|
|
2020
Q3 | $573K | Sell |
1,300
-76
| -6% | -$33.5K | 0.21% | 69 |
|
|
2020
Q2 | $499K | Buy |
1,376
+76
| +6% | +$27.6K | 0.19% | 66 |
|
|
2020
Q1 | $368K | Sell |
1,300
-60
| -4% | -$17K | 0.17% | 69 |
|
|
2019
Q4 | $441K | Buy |
+1,360
| New | +$441K | 0.15% | 80 |
|